PFG
52
7
XYL
35
4
MUR
40
4
NEM
50
2
CMS
68
3
ESS
59
5
MSI
43
2
TXT
53
4
HST
34
2
GE
64
6
LLY
59
-3
BBY
36
3
AVGO
54
2
SWKS
44
2
PGR
68
4
AMP
66
3
BXP
38
4
ZION
55
7
DOV
57
-2
DVN
29
2
PFG
52
7
XYL
35
4
MUR
40
4
NEM
50
2
CMS
68
3
ESS
59
5
MSI
43
2
TXT
53
4
HST
34
2
GE
64
6
LLY
59
-3
BBY
36
3
AVGO
54
2
SWKS
44
2
PGR
68
4
AMP
66
3
BXP
38
4
ZION
55
7
DOV
57
-2
DVN
29
2
Financhill
Back

Zealand Pharma AS 10K Form

Sell
37

ZLDPF
Zealand Pharma AS

Last Price:
$84.50
Seasonality Move:
14.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ZLDPF News And Ratings

See the #1 stock for the next 7 days that we like better than ZLDPF

ZLDPF Financial Statistics

Sales & Book Value

Annual Sales: $9.1M
Cash Flow: $-24.9M
Price / Cash Flow: 0
Annual Sales: $17.02
Price / Book: 4.97

Profitability

EPS (TTM): -2.35880
Net Income (TTM): $-156.4M
Gross Margin: $8M
Return on Equity: -17.27%
Return on Assets: -15.52%

Zealand Pharma AS Earnings Forecast

Key Zealand Pharma AS Financial Ratios

  • The Gross Profit Margin over the past 18 years for ZLDPF is 87.44%.
  • The Selling, General & Administrative Expenses for ZLDPF have been equal to 365.60% of Gross Profit Margin.
  • The Research & Development expenses have been 1,467.30% of Revenue.
  • The Net Earning history of ZLDPF is -1,720.87% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 7 years.

Zealand Pharma AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ZLDPF
Website: zealandpharma.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 21.14
Quick Ratio: 20.85

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ZLDPF Technical Analysis vs Fundamental Analysis

Sell
37
Zealand Pharma AS (ZLDPF) is a Sell

Is Zealand Pharma AS a Buy or a Sell?